Healthcare-focused private equity house ArchiMed has secured a majority stake in Cube Biotech, a Germany-based developer of membrane proteins for drug discovery.
Healthcare-focused private equity house ArchiMed has secured a majority stake in Cube Biotech, a Germany-based developer of membrane proteins for drug discovery.